Alicia Grande - 17 Aug 2021 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
VP, Treasurer and CFO
Signature
/s/ Alicia Grande
Issuer symbol
CPRX
Transactions as of
17 Aug 2021
Net transactions value
-$110,379
Form type
4
Filing time
19 Aug 2021, 17:07:54 UTC
Next filing
06 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $312,000 +100,000 +25% $3.12* 507,441 17 Aug 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $566,900 -100,000 -20% $5.67 407,441 17 Aug 2021 Direct F1, F3
transaction CPRX Common stock, par value $0.001 per share Options Exercise $218,400 +70,000 +17% $3.12* 477,441 18 Aug 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $73,879 -13,000 -2.7% $5.68 464,441 18 Aug 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -100,000 -6.7% $0.000000 1,391,334 17 Aug 2021 Common Stock 100,000 $3.12 Direct F4
transaction CPRX Options to purchase common stock Options Exercise $0 -70,000 -5% $0.000000 1,321,334 18 Aug 2021 Common Stock 70,000 $3.12 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold in various lots from $5.62 to $5.725 per share. The listed sale price represents a weighted average price for the shares sold.
F2 Shares were sold in various lots from $5.65 to $5.785 per share. The listed sale price represents a weighted average price for the shares sold.
F3 Shares were sold to cover exercise price of options and tax withholding requirements.
F4 Options vested in three annual tranches beginning on August 28, 2015.